Subscribe to Newsletter
Manufacture COVID-19

World Immunization Week

| Stephanie Vine

It’s time to celebrate World Immunization Week and the important role of COVID-19 vaccines.
Business & Regulation COVID-19

Catching Up With... Rick Bright

| Stephanie Vine

We catch up with our Power Lister Rick Bright, to get his thoughts on the future of biopharma.

Manufacture Vaccines

Saving the World, One Vial at a Time

| James Strachan

How did SiO2 quintuple their workforce and increase production capacity 12-fold in just a few months?

Discovery & Development Drug Discovery

Armored Tregs to the Rescue

| Raul Elgueta, Cristina del Carmen Rosello

What does the future hold for Tregs? Treg-cell therapy could transform the way we treat autoimmune disease and transplant rejection.

Business & Regulation Advanced Medicine

Cell and Gene Therapy: Learning from COVID-19 Vaccine Development

| James Strachan

What can the advanced therapy sector learn from COVID-19 vaccine development?

Discovery & Development Clinical Trials

Protecting the Vulnerable

| Maryam Mahdi

A trial sets out to explore the effects of various COVID-19 vaccines on vulnerable patients.
Business & Regulation Digital Technologies

Jumping into the Digital World

| Jason Lacombe

The pharma industry can no longer sit on the sidelines when it comes to digitization.

Manufacture Bioprocessing - Upstream & Downstream

Lowering Chromatography Costs

| Maryam Mahdi

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.
Manufacture Small Molecules

Celebrating Small Molecule Drug Development

We look back on key interviews and opinions from individuals featured on our 2021 Power List.
Manufacture Advanced Medicine

Keeping CRISPR On Target

| Mollie Schubert

Let’s not forget the scientists working to improve efficiency and accuracy of the CRISPR – for they are key to unlocking its full potential.

Manufacture Advanced Medicine

This Week’s CGT News: Investigating the Long-Term Safety of Gene Therapy for Hemophilia B

Manufacture Vaccines

The Front Lines of Tuberculosis Vaccine Research

Business & Regulation Standards & Regulation

FDA Plans for Shorter Drug Reviews

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker